Discover how AI-ready technology is advancing neuroplasticity research.
We are excited to introduce Blossom², SEBERS Medical’s next-generation research TMS platform, designed to provide researchers with unprecedented flexibility for exploring advanced neuromodulation and neuroplasticity.
Built on a completely new hardware and software architecture, Blossom² supports a wide range of stimulation paradigms, including high-frequency rTMS, paired-pulse protocols, burst stimulation, Quadri-Pulse Stimulation (QPS), and individualized research applications. Its modular, AI-ready design has been developed to support future innovations in closed-loop stimulation and adaptive research workflows.
With Blossom², our goal is to provide researchers with a platform that goes beyond conventional TMS systems—offering the flexibility to investigate new stimulation strategies while maintaining the intuitive user experience and reliability that define SEBERS Medical.
We look forward to collaborating with research institutions worldwide as we continue advancing the future of non-invasive brain stimulation.
Discover the future of research TMS: Visit our Research Products page to learn more about Blossom² and our vision for next-generation neuromodulation.
→ Read here for more information!
We make TMS easy!
Blossom² is an investigational research platform and has not received regulatory approval or clearance for clinical use.
